News

Caregility Welcomes Susan Kristiniak as New CNO to Drive Change

Caregility Welcomes Susan Kristiniak as New CNO to Drive Change

Caregility Announces New Chief Nursing Officer

Caregility Corporation has made a significant announcement, revealing that Susan Kristiniak, a seasoned healthcare professional, has been appointed as the new Chief Nursing Officer (CNO). Susan's extensive background in both clinical care and executive leadership positions her uniquely to drive improvements in care delivery across various healthcare organizations. She is set to lead the clinical team at Caregility, ensuring the integration of innovative solutions in the realm of virtual care.

Bridging Clinical and Operational Needs

With a remarkable career encompassing hands-on clinical roles and high-level strategic positions, Susan Kristiniak aims to bridge the crucial divide between clinical needs and operational strategy. Her experience enables her to offer valuable insights that enhance Caregility’s commitment to delivering high-quality care. The incorporation of her expertise is anticipated to augment the organization’s capacity to provide measurable value to healthcare providers while prioritizing care quality and operational efficiency.

Experience That Matters

Before joining Caregility, Susan held the position of Vice President of Clinical Integration and Quality Assurance, where she led initiatives centered around optimizing hospital operations through a data-informed approach. Her work involved close collaboration with high-ranking executives—including CEOs, COOs, and CNOs—to dissect hospital data, create multidisciplinary teams, and execute projects aimed at elevating nursing practices and patient safety outcomes.

Company’s Growth and Adaptation

Mike Brandofino, President and COO of Caregility, recognized the significant growth the company has achieved, particularly in expanding virtual nursing services. He remarked, "As more health systems develop their inpatient virtual care programs, Caregility has emerged as an essential partner for these organizations. Susan’s deep understanding of both the clinical and executive facets of healthcare will be vital as we strive to enhance the value provided to our partners." This forward momentum underscores Caregility's role not only in the clinical space but also in corporate and operational discussions within healthcare.

Susan Kristiniak’s Commitment

Expressing her enthusiasm about joining Caregility, Susan Kristiniak stated, "I am thrilled to join Caregility and contribute to the company’s continued evolution as the leader in virtual care platforms. My goal is to strengthen our relationships with healthcare systems and ensure that our customers can achieve the full potential of the clinical and economic benefits our solutions offer." This commitment reflects Caregility’s continuous drive for innovation and excellence in virtual healthcare.

Strengthening Caregility’s Clinical Focus

Ron Gaboury, CEO of Caregility, commended Susan’s unique skill set which marries clinical expertise with financial insight, emphasizing the need for a connection between clinical innovations and operational strategies. He mentioned, "With Susan’s leadership, we will enhance our clinical focus, driving crucial discussions about the economic advantages of virtual care while maintaining the highest clinical standards." This dual focus on quality and operational efficiency is vital to meeting the evolving demands of modern healthcare.

Caregility’s Vision for Modern Healthcare

Under Susan Kristiniak’s leadership, Caregility is poised to make strides in healthcare modernization, focusing on innovative virtual care solutions that promise to elevate outcomes for both patients and providers. The company’s commitment to leveraging advanced technologies in telehealth signifies a promising future for patients and healthcare systems alike.

About Caregility

Caregility Corporation is dedicated to revolutionizing the healthcare experience through its Caregility Cloud™ virtual care platform. Recognized as the Best in KLAS Virtual Care Platform in 2021, 2022, and 2023, Caregility Cloud™ supports a robust ecosystem of telehealth solutions across the continuum of care. The company ensures secure, reliable, and HIPAA-compliant communication across various devices and clinical environments, impacting over 1,000 hospitals and hosting more than five million virtual care sessions each year. Caregility is committed to connecting care throughout various healthcare settings, from acute to post-acute and ambulatory care.

Frequently Asked Questions

Who is Susan Kristiniak?

Susan Kristiniak is the newly appointed Chief Nursing Officer of Caregility, bringing extensive clinical and executive experience to the role.

What does Caregility focus on?

Caregility focuses on providing innovative virtual care solutions and enterprise telehealth services to healthcare organizations across the continuum of care.

How does Caregility ensure quality in virtual care?

Caregility maintains a strong emphasis on quality care while optimizing operational efficiency through its advanced telehealth platforms.

What recognition has Caregility received?

Caregility has been recognized as the Best in KLAS Virtual Care Platform in 2021, 2022, and 2023, highlighting its leadership in the industry.

How many hospitals does Caregility support?

Caregility currently supports over 1,000 hospitals across more than 85 health systems with millions of virtual care sessions annually.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 4

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading

Top 5 Most Recently Viewed Articles

NotHappening Launches Unique Luxury Streetwear in NYC

Updated Category News Views 456

A Bold Fashion Statement: NotHappening Launches Today, a remarkable fashion phenomenon has emerged, capturing the imagination of enthusiasts and critics alike. NotHappening, a daring new brand, has made its grand entrance into the world of luxury streetwear, and it's more than just a fashion label; it's a commentary on contemporary culture and the pervasive influence of...

Continue Reading
Hormone Evaluation Steps: Insights from Annette Asper

Updated Category News Views 27

Navigating Hormone Evaluations with Clarity In the labyrinth of healthcare, figuring out what's crucial for your well-being can be a tangled mess. Today's focus is unraveling the often-overlooked world of hormone evaluations. It's not just about popping pills based on hunches—it's about getting a well-rounded picture of your health. Annette Asper from Rewritten Klinik...

Continue Reading
Radix Launches Innovations in Asset Integrity at Amsterdam Event

Updated Category News Views 101

Radix Showcases Innovations in Digital Twin Technology Radix is all set to unveil its groundbreaking innovations in asset integrity and energy transition at the renowned Future Digital Twin & Generative AI Conference. Hosted at the Energy Transition Campus in Amsterdam, this event is a gathering of industry experts and technology leaders aimed at tackling significant...

Continue Reading
Genmab Gets FDA Approval for Epcoritamab Combo for Lymphoma

Updated Category News Views 182

Genmab's Epcoritamab Combination Therapy Approved Company Announcement Genmab A/S (NASDAQ: GMAB) has achieved an important milestone with the FDA's approval of Epcoritamab, marketed as EPKINLY®, combined with rituximab and lenalidomide, a trio set to offer hope to adults suffering from relapsed or refractory follicular lymphoma (R/R FL). Pivotal Phase 3 Study Results The...

Continue Reading
EchoStar Corporation Posts Strong Growth in Q2 Financials

Updated Category News Views 171

EchoStar Corporation Financial Results Overview EchoStar Corporation (NASDAQ: SATS) has released its impressive financial results for the recently concluded quarter. The results indicate a robust performance, emphasizing growth across several key business areas. The company has focused on enhancing its operational efficiencies while ensuring that customer experiences are...

Continue Reading